Abbott Launches Sweeping Review of IVF Ethics
By Sunshine Coast Daily,
Sunshine Coast Daily [Australia]
| 03. 17. 2014
THE ethical rules governing the use of egg and sperm donations, embryos, surrogacy and sex selection for IVF patients could soon be overhauled, with a sweeping review underway.
Officially opened for consultation last week, the Abbott government review of the ethical guidelines for "assisted reproductive technology" will close for submissions in late April.
The review will look at controversial ethical aspects of the use of human embryos, egg and sperm donations, among a wide range of other uses of the technology.
Run by the National Health and Medical Research Council, the review will ask the IVF industry, community and ethics groups about "gaps" in the existing guidelines, last updated in 2007.
The review will be led by a host of IVF industry scientists and medical practitioners, under chairman Ian Olver, chief executive of the Cancer Council of Australia.
It will specifically cover the ethical conundrums facing IVF patients and doctors, from access to information on donors to the children born through IVF to the use of embryos in research.
The review further opens the door to potential changes to rules...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...